AVL-292

Product Name: AVL-292
CAS No.: 1202757-89-8
Chemical Name: AVL-292
Synonyms: CS-733;CC-292;LMK-435;AVL-292;Spebrutinib;AVL-292 >=98%;CC-292,LMK-435;CC-292 (AVL-292);AVL 292 - CC 292;AVL-292 USP/EP/BP
CBNumber: CB02655392
Molecular Formula: C22H22FN5O3
Formula Weight: 423.44
MOL File: 1202757-89-8.mol

More

Less

AVL-292 Property

Density: 1.322±0.06 g/cm3(Predicted)
storage temp.: Store at -20°C
solubility: ≥21.15 mg/mL in DMSO; insoluble in H2O; ≥4.9 mg/mL in EtOH with gentle warming and ultrasonic
form: solid
pka: 13.22±0.70(Predicted)
CAS DataBase Reference: 1202757-89-8

More

Less

Hazard and Precautionary Statements (GHS)

More

Less

N-Bromosuccinimide Price

Cayman Chemical

Product number: 17993
Product name: AVL-292
Purity: ≥98%
Packaging: 1mg
Price: $44
Updated: 2024/03/01

Cayman Chemical

Product number: 17993
Product name: AVL-292
Purity: ≥98%
Packaging: 5mg
Price: $193
Updated: 2024/03/01

Cayman Chemical

Product number: 17993
Product name: AVL-292
Purity: ≥98%
Packaging: 10mg
Price: $341
Updated: 2024/03/01

Cayman Chemical

Product number: 17993
Product name: AVL-292
Purity: ≥98%
Packaging: 50mg
Price: $957
Updated: 2024/03/01

TRC

Product number: A794715
Product name: AVL-292
Packaging: 100mg
Price: $610
Updated: 2021/12/16

More

Less

AVL-292 Chemical Properties,Usage,Production

Uses

Bruton’s tyrosine kinase (BTK) is a non-receptor tyrosine kinase involved in signal transduction pathways regulating the proliferation, activation, and differentiation of B cells. AVL-292 is an orally available, selective, and irreversible inhibitor of BTK (IC50 = 0.5 nM in vitro in B cell lymphoma cell lines) that targets and covalently binds to BTK at cysteine-481, thereby preventing its activity. AVL-292 has been shown to inhibit osteoclast function and to reduce osteoclast-stimulated proliferation of multiple myeloma cells in animal models of rheumatoid arthritis and multiple sclerosis, both of which are diseases where B cells play an important role. In clinical trials, AVL-292 has demonstrated therapeutic significance in the treatment of both B cell-related cancers (e.g., non-Hodgkin’s lymphoma and B cell chronic lymphocytic leukemia) and autoimmune diseases (e.g., rheumatoid arthritis).[Cayman Chemical]

target

Btk

AVL-292 Preparation Products And Raw materials

Raw materials

Preparation Products

More

Less

AVL-292 Suppliers

China 132 India 2 United Kingdom 1 United States 19 Global 154

MedChemexpress LLC

Tel: 021-58955995
Fax: 609-228-5909
Email: sales@medchemexpress.cn
Country: United States
ProdList: 4863
Advantage: 58

AdooQ BioScience, LLC

Tel: +1 (866) 930-6790
Fax: +1 (866) 333-9607
Email: info@adooq.com
Country: United States
ProdList: 2784
Advantage: 58

Target molecule Corp.

Tel: 857-239-0968
Fax: 857-239-8801
Email: service1@targetmol.com
Country: United States
ProdList: 2559
Advantage: 60

Musechem

Tel: +1-800-259-7612
Fax: +1-800-259-7612
Email: info@musechem.com
Country: United States
ProdList: 4662
Advantage: 60

TargetMol Chemicals Inc.

Tel: +1-781-999-5354 +1-00000000000
Email: marketing@targetmol.com
Country: United States
ProdList: 19892
Advantage: 58

InvivoChem

Tel: +1-708-310-1919 +1-13798911105
Fax: 708-557-7486
Email: sales@invivochem.cn
Country: United States
ProdList: 6393
Advantage: 58

Cckinase, Inc.

Tel: +1 (732)236-3202
Email: sales@cckinase.com
Country: United States
ProdList: 2738
Advantage: 58

BOC Sciences

Tel: +1-631-485-4226
Fax: 1-631-614-7828
Email: inquiry@bocsci.com
Country: United States
ProdList: 19553
Advantage: 58

Aladdin Scientific

Tel: +1-833-552-7181
Email: sales@aladdinsci.com
Country: United States
ProdList: 57511
Advantage: 58

More

Less

View Lastest Price from AVL-292 manufacturers

Zhejiang J&C Biological Technology Co.,Limited

Product: AVL-292 1202757-89-8
Price: US $0.00/gram
Min. Order: 1gram
Purity: 99%
Supply Ability: 10kg
Release date: 2022-02-17

Career Henan Chemical Co

Product: AVL-292 1202757-89-8
Price: US $2.00/kg
Min. Order: 1kg
Purity: 99%
Supply Ability: 100kg
Release date: 2018-12-24

1202757-89-8, AVL-292Related Search:

Dabrafenib CAL-101 CO-1686 Ibrutinib AZD-9291 CNX-774

AVL-292

LMK-435

N-[3-[[5-Fluoro-2-[[4-(2-methoxyethoxy)phenyl]amino]-4-pyrimidinyl]amino]phenyl]-2-propenamide

2-Propenamide, N-[3-[[5-fluoro-2-[[4-(2-methoxyethoxy)phenyl]amino]-4-pyrimidinyl]amino]phenyl]-

CC-292 (AVL-292)

CC-292,LMK-435

N-[3-[[5-Fluoro-2-[[4-(2-methoxyethoxy)phenyl]amino]-4-pyrimidinyl]amino]phenyl]-2-propenamide AVL292

CC-292

Spebrutinib

N-(3-((5-fluoroethoxy)phenyl)amino)pyrimidin-4-yl)amino)phenyl)acrylamide

CS-733

N-(3-((5-fluoroethoxy)phenyl)amino)pyrimidin-4-yl)amino)phenyl)acrylamide (AVL-292)

CC-292; AVL292; AVL-292; AVL 292

AVL 292 - CC 292

CC-292;AVL292;AVL-292;AVL 292;SPEBRUTINIB

AVL-292 (Spebrutinib)

AVL-292 >=98%

N-(3-((5-fluoro-2-((4-(2-methoxyethoxy)phenyl)amino)pyrimidin-4-yl)amino)phenyl)acrylamide

Spebrutinib (AVL-292)

Spebrutinib (CC-292, AVL-292)

N-{3-[(5-Fluoro-2-{[4-(2-methoxyethoxy)phenyl]amino}pyrimidin-4-yl)amino]phenyl}prop-2-enamide

AVL-292 USP/EP/BP

Spebrutinib (CC292

7-Epoxytropine hydrochloride

1202757-89-8

Inhibitors